Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Kreft

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|July 10, 1992
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitorsJ H Musser, A F Kreft
Agents and Actions|June 1, 1986
New developments concerning leukotriene antagonists: a reviewJ H Musser, A F Kreft, A J Lewis
Biochemical Pharmacology|May 1, 1985
Inhibition of platelet and neutrophil phospholipase A2 by hydroxyeicosatetraenoic acids (HETES). A novel pharmacological mechanism for regulating free fatty acid releaseJ Chang, E Blazek, A F Kreft, et al.
European Journal of Pharmacology|January 2, 1985
Modulation by hydroxyeicosatetraenoic acids (HETEs) of arachidonic acid metabolism in mouse resident peritoneal macrophagesJ Chang, B Lamb, L Marinari, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1989
Wy-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]methane sulfonamide) an orally active leukotriene D4 antagonist: pharmacological characterization in vitro and in vivo in the guinea pigJ M Hand, S F Schwalm, M A Auen, et al.
Prostaglandins|February 1, 1989
Pharmacological characterization using selected antagonists of the leukotriene receptors mediating contraction of guinea-pig tracheaJ M Hand, S F Schwalm, I M Englebach, et al.
Agents and Actions|March 1, 1989
Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammationR P Carlson, L O'Neill-Davis, W Calhoun, et al.
Journal of Medicinal Chemistry|June 1, 1989
N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structureJ H Musser, A F Kreft, R H Bender, et al.
Journal of Medicinal Chemistry|January 1, 1990
N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structureJ H Musser, A F Kreft, R H Bender, et al.
European Journal of Pharmacology|May 19, 1993
WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activityD Grimes, R J Sturm, L R Marinari, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|July 10, 1992
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitorsJ H Musser, A F Kreft
Agents and Actions|June 1, 1986
New developments concerning leukotriene antagonists: a reviewJ H Musser, A F Kreft, A J Lewis
Biochemical Pharmacology|May 1, 1985
Inhibition of platelet and neutrophil phospholipase A2 by hydroxyeicosatetraenoic acids (HETES). A novel pharmacological mechanism for regulating free fatty acid releaseJ Chang, E Blazek, A F Kreft, et al.
European Journal of Pharmacology|January 2, 1985
Modulation by hydroxyeicosatetraenoic acids (HETEs) of arachidonic acid metabolism in mouse resident peritoneal macrophagesJ Chang, B Lamb, L Marinari, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1989
Wy-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]methane sulfonamide) an orally active leukotriene D4 antagonist: pharmacological characterization in vitro and in vivo in the guinea pigJ M Hand, S F Schwalm, M A Auen, et al.
Prostaglandins|February 1, 1989
Pharmacological characterization using selected antagonists of the leukotriene receptors mediating contraction of guinea-pig tracheaJ M Hand, S F Schwalm, I M Englebach, et al.
Agents and Actions|March 1, 1989
Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammationR P Carlson, L O'Neill-Davis, W Calhoun, et al.
Journal of Medicinal Chemistry|June 1, 1989
N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structureJ H Musser, A F Kreft, R H Bender, et al.
Journal of Medicinal Chemistry|January 1, 1990
N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structureJ H Musser, A F Kreft, R H Bender, et al.
European Journal of Pharmacology|May 19, 1993
WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activityD Grimes, R J Sturm, L R Marinari, et al.
Pageof 2